Quarterly report pursuant to Section 13 or 15(d)

SHARE CAPITAL (Tables)

v3.23.1
SHARE CAPITAL (Tables)
3 Months Ended
Mar. 31, 2023
Equity [Abstract]  
SCHEDULE OF SHARE CAPITAL

The Company had the following common share transactions for the three months ended March 31, 2023:

 

    Three months ended March 31, 2023  
    # of shares     Amount  
Common shares issued for conversion of convertible debt     710,807     $ 1,048,573  
Common shares issued for compensation     155,898       105,512  
Common shares issued for consulting services     15,000       27,735  
Common shares issued on conversion of vested prefunded warrants     1,637,049       2,959,108  
Total common shares issued     2,518,754     $ 4,140,928  

 

The Company had the following common share transactions for the three months ended March 31, 2022:

 

    Three months ended March 31, 2022  
    # of shares     Amount  
Common shares issued for consulting services     40,997     $ 88,071  
Common shares issued for compensation     29,317       97,121  
Total common shares issued     70,314     $ 185,192  
SCHEDULE OF ANTI-DILUTIVE SECURITIES EXCLUDED FROM COMPUTATION OF EARNINGS PER SHARE

Potentially dilutive securities that are not included in the calculation of diluted net loss per share because their effect is anti-dilutive are as follows (in common equivalent shares):

 

   

March 31,

2023

   

March 31,

2022

 
Warrants     12,537,969       5,770,262  
Options     1,382,629       717,019  
Convertible debentures     11,358,526       -  
Total anti-dilutive weighted average shares     25,279,124       6,487,281